Gilad Shabtai, 10% Owner at Eloxx Pharmaceuticals, Inc. (ELOX), bought 8,300 shares at $9.41 ($79K) on 2018-04-03, disclosed to the SEC on 2018-04-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.41 | 5,700 | $54K | 68.3% |
| 2 | $9.58 | 2,600 | $25K | 31.7% |
| Total | $9.46 avg | 8,300 | $79K | 100% |
| Filing → |